Page 60 - Read Online

Yagawa et al. Cancer immunity and hyperthermia

Minderman H, Repasky EA. Differentiation of CD8+ T cells into 2013;10:230-52.
effector cells is enhanced by physiological range hyperthermia. J 62. Screpanti V, Wallin RP, Grandien A, Ljunggren HG. Impact of FASL-
Leukoc Biol 2011;90:951-62. induced apoptosis in the elimination of tumor cells by NK cells. Mol
44. Minamiya Y, Saito H, Takahashi N, Ito M, Toda H, Ono T, Konno H, Immunol 2005;42:495-9.
Motoyama S, Ogawa J. Expression of the chemokine receptor CCR6 63. Takeda K, Hayakawa Y, Smyth MJ, Kayagaki N, Yamaguchi N,
correlates with a favorable prognosis in patients with adenocarcinoma Kakuta S, Iwakura Y, Yagita H, Okumura K. Involvement of tumor
of the lung. Tumour Biol 2011;32:197-202. necrosis factor-related apoptosis-inducing ligand in surveillance of
45. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen tumor metastasis by liver natural killer cells. Nat Med 2001;7:94-100.
PM, Dustin ML. The immunological synapse: a molecular machine 64. Dayanc BE, Beachy SH, Ostberg JR, Repasky EA. Dissecting the role
controlling T cell activation. Science 1999;285:221-7. of hyperthermia in natural killer cell mediated anti-tumor responses.
46. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three- Int J Hyperthermia 2008;24:41-56.
dimensional segregation of supramolecular activation clusters in T 65. Ostberg JR, Dayanc BE, Yuan M, Oflazoglu E, Repasky EA.
cells. Nature 1998;395:82-6. Enhancement of natural killer (NK) cell cytotoxicity by fever-range
47. Ostberg JR, Kaplan KC, Repasky EA. Induction of stress proteins in thermal stress is dependent on NKG2D function and is associated
a panel of mouse tissues by fever-range whole body hyperthermia. Int with plasma membrane NKG2D clustering and increased expression
J Hyperthermia 2002;18:552-62. of MICA on target cells. J Leukoc Biol 2007;82:1322-31.
48. Tsan MF, Gao B. Heat shock proteins and immune system. J Leukoc 66. Terunuma H, Deng X, Toki A, Yoshimura A, Nishino N, Takano
Biol 2009;85:905-10. Y, MIE Nieda M, Sasanuma J, Teranishi Y, Watanabe K. Effects
49. Srivastava PK, Udono H, Blachere NE, Li Z. Heat shock proteins of hyperthermia on the host immune system: from NK cell-based
transfer peptides during antigen processing and CTL priming. science to clinical application. Thermal Med 2012;28:1-9.
Immunogenetics 1994;39:93-8. 67. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner
50. Binder RJ, Srivastava PK. Peptides chaperoned by heat-shock HL, Kuchroo VK. Reciprocal developmental pathways for the
proteins are a necessary and sufficient source of antigen in the cross- generation of pathogenic effector TH17 and regulatory T cells.
priming of CD8+ T cells. Nat Immunol 2005;6:593-9. Nature 2006;441:235-8.
51. Breloer M, Dorner B, Moré SH, Roderian T, Fleischer B, von Bonin 68. Smyth MJ, Teng MW, Swann J, Kyparissoudis K, Godfrey DI,
A. Heat shock proteins as “danger signals”: eukaryotic Hsp60 Hayakawa Y. CD4+CD25+ T regulatory cells suppress NK cell-
enhances and accelerates antigen-specific IFN-gamma production in mediated immunotherapy of cancer. J Immunol 2006;176:1582-7.
T cells. Eur J Immunol 2001;31:2051-9. 69. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T.
52. Ramp U, Mahotka C, Heikaus S, Shibata T, Grimm MO, Willers Regulatory T cells: how do they suppress immune responses? Int
R, Gabbert HE. Expression of heat shock protein 70 in renal cell Immunol 2009;21:1105-11.
carcinoma and its relation to tumor progression and prognosis. Histol 70. Oleinika K, Nibbs RJ, Graham GJ, Fraser AR. Suppression,
Histopathol 2007;22:1099-107. subversion and escape: the role of regulatory T cells in cancer
53. Mashaghi A, Bezrukavnikov S, Minde DP, Wentink AS, Kityk progression. Clin Exp Immunol 2013;171:36-45.
R, Zachmann-Brand B, Mayer MP, Kramer G, Bukau B, Tans SJ. 71. Curiel TJ. Tregs and rethinking cancer immunotherapy. J Clin Invest
Alternative modes of client binding enable functional plasticity of 2007;117:1167-74.
Hsp70. Nature 2016;539:448-51. 72. Terunuma H, Wada A, Deng X, Yasuma Y, Onishi T, Toki A, Abe H.
54. Wang Y, Gao B, Tsan MF. Induction of cytokines by heat shock Mild hyperthermia modulates the relative frequency of lymphocyte
proteins and concanavalin A in murine splenocytes. Cytokine cell subpopulations: an increase in a cytolytic NK cell subset and a
decrease in a regulatory T cell subset. Thermal Med 2007;23:41-7.
2005;32:149-54.
55. Terunuma H, Deng X, Dewan Z, Fujimoto S, Yamamoto N. Potential 73. Guo J, Zhu J, Sheng X, Wang X, Qu L, Han Y, Liu Y, Zhang H,
Huo L, Zhang S, Lin B, Yang Z. Intratumoral injection of dendritic
role of NK cells in the induction of immune responses: implications cells in combination with local hyperthermia induces systemic
for NK cell-based immunotherapy for cancers and viral infections. antitumor effect in patients with advanced melanoma. Int J Cancer
Int Rev Immunol 2008;27:93-110. 2007;120:2418-25.
56. Pandha H, Rigg A, John J, Lemoine N. Loss of expression of antigen- 74. Terunuma H. Potentiating immune system by hyperthermia. In:
presenting molecules in human pancreatic cancer and pancreatic Kokura S, Yoshikawa T, Ohnishi T, editors. Hyperthermic oncology
cancer cell lines. Clin Exp Immunol 2007;148:127-35. from bench to bedside. Singapore: Springer Singapore; 2016. p. 127-
57. Koopman LA, Corver WE, van der Slik AR, Giphart MJ, Fleuren GJ. 35.
Multiple genetic alterations cause frequent and heterogeneous human 75. Hatzfeld-Charbonnier AS, Lasek A, Castera L, Gosset P, Velu
histocompatibility leukocyte antigen class I loss in cervical cancer. J T, Formstecher P, Mortier L, Marchetti P. Influence of heat
Exp Med 2000;191:961-76. stress on human monocyte-derived dendritic cell functions with
58. Madjd Z, Spendlove I, Pinder SE, Ellis IO, Durrant LG. Total loss of immunotherapeutic potential for antitumor vaccines. J Leukoc Biol
MHC class I is an independent indicator of good prognosis in breast 2007;81:1179-87.
cancer. Int J Cancer 2005;117:248-55. 76. TanigawaK, ItoY, KobayashiY. Effects of fever-range hyperthermia
59. Kitamura H, Torigoe T, Asanuma H, Honma I, Sato N, Tsukamoto on t cell-mediated immunity: possible combination of hyperthermia
T. Down-regulation of HLA class I antigens in prostate cancer and t cell-based cancer immunotherapy. Available from: https://link.
tissues and up-regulation by histone deacetylase inhibition. J Urol springer.com/chapter/10.1007/978-981-10-0719-4_31#citeas. [Last
2007;178:692-6. accessed on 19 Oct 2017]
60. Djajadiningrat RS, Horenblas S, Heideman DA, Sanders J, de Jong 77. Mallory M, Gogineni E, Jones GC, Greer L, Simone CB 2nd.
J, Jordanova ES. Classic and nonclassic HLA class I expression in Therapeutic hyperthermia: The old, the new, and the upcoming. Crit
penile cancer and relation to HPV status and clinical outcome. J Urol Rev Oncol Hematol 2016;97:56-64.
2015;193:1245-51. 78. Jorritsma JB, Burgman P, Kampinga HH, Konings AW. DNA
61. Cheng M, Chen Y, Xiao W, Sun R, Tian Z. NK cell-based polymerase activity in heat killing and hyperthermic radiosensitization
immunotherapy for malignant diseases. Cell Mol Immunol of mammalian cells as observed after fractionated heat treatments.
Journal of Cancer Metastasis and Treatment ¦ Volume 3 ¦ October 31, 2017 229